Entry Point Capital, LLC Sutro Biopharma, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 40,985 shares of STRO stock, worth $79,510. This represents 0.08% of its overall portfolio holdings.
Number of Shares
40,985Holding current value
$79,510% of portfolio
0.08%Shares
2 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
61MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.9 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$13.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$8.14 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.82 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.49 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $101M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...